Atlas Trials

Active Moderate to Severe Rheumatoid Arthritis

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Active Moderate to Severe Rheumatoid Arthritis

RecordFirmDate
Korean Post-marketing Surveillance for Xeljanz XR (NCT04876781)Pfizer2022-01-12
A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes (NCT00642629)Synta Pharmaceuticals Corp.2005-12-01

Track Active Moderate to Severe Rheumatoid Arthritis automatically

Every clearance here is in the API, with alerts when new ones post.